Esperion Therapeutics | Liquidités

Cash And Equivalent Changement Date
AbbVie USD 13.29B 4.53B 2023-09
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amarin USD 270.81M 37.82M 2023-09
Amgen USD 10.94B 23.8B 2023-12
Biogen USD 1.05B 1.24B 2023-12
BioMarin Pharmaceutical USD 755.13M 30.29M 2023-12
Cytokinetics USD 113.02M 13.33M 2023-12
Daiichi Sankyo JPY 590.77B 71.1B 2023-09
Eli Lilly USD 2.38B 313.7M 2023-09
Geron USD 70.02M 39.31M 2023-12
Grifols EUR 484.23M 39.13M 2023-09
Halozyme Therapeutics USD 118.37M 155.86M 2023-12
Intra Cellular Therapies USD 147.77M 48.36M 2023-12
Ionis Pharmaceuticals USD 399.27M 47.21M 2023-12
Merck USD 8.6B 2.94B 2023-09
Moderna USD 2.91B 25M 2023-12
Pfizer USD 3.15B 516M 2023-09
PTC Therapeutics USD 594M 428.84M 2023-12
Regeneron Pharmaceuticals USD 16.24B 14.09B 2023-12
Sarepta Therapeutics USD 541.93M 310M 2023-09
United Therapeutics USD 1.21B 100M 2023-12



Esperion Therapeutics Liquidités - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.